Tenderwize
Retour à la recherche

Medicines contracts with joining option

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2027 · 245 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarder
Titre original de l'avis

Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

42/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

42 / 100

Complexité

58 / 100

Facteurs de risque

The notice explicitly states that it is not a public contract within the meaning of Directive 2014/24/EU or German proc...

The XML notice states that Lot 2 was cancelled.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 2 lots
  • Duration until Sep 2027
  • Framework supply agreement with accession option for pharmaceutical products.
  • Lot 1 covers medicines containing liraglutide, excluding lifestyle medicines.
Afficher le résumé complet

This is a German framework agreement with accession option for pharmaceutical products (CPV 33600000), led by BARMER Beschaffung und Vergabe. The notice explicitly states it is not a public contract under procurement law, although the form uses an open procedure label. Two lots are listed: Liraglutid and Ticagrelor. Submission is electronic via https://beschaffungen.barmer.de/ and the deadline is 2027-05-01 10:00 UTC (12:00 local time in the XML). No contract value is provided in the structured data or XML. The XML also indicates Lot 2 was cancelled.

Risques

The notice explicitly states that it is not a public contract within the meaning of Directive 2014/24/EU or German proc...

The XML notice states that Lot 2 was cancelled.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Electronic submission via Ouvrir le portail is allowed.
  • Submission deadline: 2027-05-01 10:00 UTC (XML shows 12:00 local time).
  • The notice states that procurement documents can be downloaded free of charge from the internet; paper copies are not available.

Acheteur

Localisation

Wuppertal, DEU

Identifiant

992-80322-57

Activité

Health

Lots (2)

LOT-0001

Liraglutide (excluding lifestyle medicines)

Framework supply lot for medicines containing the active substance(s) named in the lot title. Performance location is Wuppertal, Germany. The lot is part of a framework agreement with accession option. No lot value or lot-specific award criteria are provided.

SuppliesFrameworkEU fundedElectronic submission

Localisation

Wuppertal, Germany

Durée

May 2025 - Sep 2027

Catégorie

Pharmaceutical products

Date limite

Deadline May 01, 2027

LOT-0002

Ticagrelor

Framework supply lot for medicines containing the active substance(s) named in the lot title. Performance location is Wuppertal, Germany. The lot is part of a framework agreement with accession option. No lot value or lot-specific award criteria are provided. The XML notice states that Lot 2 was cancelled.

SuppliesFrameworkEU fundedElectronic submission

Localisation

Wuppertal, Germany

Durée

May 2025 - Sep 2027

Catégorie

Pharmaceutical products

Date limite

Deadline May 01, 2027

Détails de la procédure

Date de publication
25 Aug 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
556029-2025

Documents (1)

Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30